Rx Statin "Black Box" Petition Could Affect OTC Switch Considerations
This article was originally published in The Tan Sheet
Executive Summary
The chances of cholesterol-lowering statins switching OTC would appear slim if FDA were to grant a Public Citizen Health Research Group petition requesting all such Rx drugs carry a "black box" warning about the risk of rhabdomyolysis.